Biopharmaceuticals Analyst Ding holds a group dinner meeting at the American Heart Association (AHA) Meeting in Chicago on November 7 hosted by Jefferies.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CINC:
- CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data on Baxdrostat in Treatment-Resistant Hypertension at the 2022 American Heart Association Scientific Sessions
- CinCor Pharma Announces Publication in the New England Journal of Medicine of Phase 2 BrigHtn Data on Selective Aldosterone Synthase Inhibitor Baxdrostat in Treatment-Resistant Hypertension
- CinCor Pharma appoints Kalb as EVP, CFO
- Correcting and Replacing: CinCor Reports Third Quarter Financial Results and Provides Corporate Update
- CinCor Reports Third Quarter Financial Results and Provides Corporate Update